What MOQ actually measures
A 500-unit capsule batch costs more per unit than a 5,000-unit batch because setup, testing, and procurement costs are spread across fewer units. That difference comes from fixed work such as batch record preparation and analytical testing, which does not shrink in proportion to batch size.
Seeing that structure helps a growing brand decide when a small pilot is sensible and when a larger run is justified. The lowest per-unit price is not automatically the soundest choice. At Leumas, we can use AI-assisted batch scheduling to plan around the selected tier, but the quantity still needs to fit the brand's cash position and demand evidence.
Minimum order quantity is the smallest batch a CDMO will produce for a particular formula and dosage form. It exists because every run has a cost floor. Preparation, line use, testing, and production records still require work when the unit count is low.
MOQ also reflects quality testing requirements. Dissolution and microbial limit tests, for example, may need enough sample units for the method to produce a valid result. Making fewer units does not necessarily reduce that testing work, so a very small order can carry a disproportionate cost.
Our capsule floor is 500 units because it covers both fixed-run recovery and the testing minimum. Powders and gummies use different minimums because their batch requirements and production processes are different.
How CDMO pricing tiers work
CDMO quotes commonly separate a low-quantity pilot tier, a mid-volume production tier, and a higher volume tier. The per-unit rate usually falls as quantity rises because setup and purchasing costs are distributed over more finished units.
The costs that move most between tiers are batch setup and ingredient purchasing. A pilot may need quantities below a supplier's purchase minimum, which can leave the CDMO paying a less favorable ingredient price. At higher volumes, that constraint may ease.
Finished-goods testing usually changes much less between tiers. A capsule panel covering potency assay, microbial limits, and heavy metals can remain close to 3,000 whether the batch is small or large. That fixed charge has a much larger per-unit effect at 500 units than at 5,000 units, and the quote should make the 18-related testing line clear rather than hiding it in the unit rate.
Choosing your first batch size
For a first formula, choose the smallest batch that lets you test market response without tying up too much working capital. For many supplement formats, 500 units provides a practical middle ground between a meaningful launch and an oversized commitment.
Some brands use a pilot or sample program first, making 50 to 100 units for gifting or influencer seeding. That can help test initial interest before the first production batch, although it does not replace evidence from actual sales.
Packaging can set a separate constraint. Custom labels or boxes may have supplier minimums of 1,000 to 2,500 units, and a quote may reach 3,000 packaged units even when the product run itself is smaller. Check packaging quantities before selecting the product MOQ.
When to move up a tier
Move from the pilot tier to production quantities when demand supports the commitment, not simply because the larger run has a lower unit price. A 5,000-unit order is poor value if the additional stock sits unsold and absorbs working capital.
A useful operating signal is consistent pilot sell-through within 60 to 90 days of receipt. If a 500-unit batch sells within that period and stockouts are becoming a problem, the 5,000-unit tier may deserve review.
The production tier can also improve supply planning. Larger ingredient purchases may bring better raw material pricing, while the bigger run can provide more scheduling flexibility than a pilot.
What MOQ cannot fix
MOQ optimization does not substitute for formula validation. It only makes the decision cleaner once demand evidence is clear. Producing 5,000 units before confirming that customers want the formula and will purchase it again does not solve the underlying business problem.
We tell brands this directly when reviewing a quote. If the first pilot has not sold through, we can price the next production run, but we will also ask whether the available demand evidence supports the larger commitment. That conversation is part of choosing the right tier.